Burden of thyroid cancer in China and worldwide from 1990 to 2021: observation, comparison, and forecast from the Global Burden of Disease Study 2021
It is imperative to avoid over-screening and over-treatments for TC. Meanwhile, we should also avoid missing aggressive types of TC that may have an impact on overall survival. Additionally, understanding the mechanisms of metastasis and improving clinical treatments should be prioritized for further investigation. TC remains a significant public health challenge in China, necessitating a careful balance of the cost-benefit ratio.
Authors
- Dongbo Xue (ORCID: https://orcid.org/0000-0001-9012-4805)
- Ziang Meng
- Biao Ma (ORCID: https://orcid.org/0000-0002-6387-0957)
- Xuxu Liu (ORCID: https://orcid.org/0000-0001-5408-4746)
- Jing Wang (ORCID: https://orcid.org/0000-0003-1580-1356)
- Jingjing Yu (ORCID: https://orcid.org/0000-0001-5822-4486)
- Chao Shi (ORCID: https://orcid.org/0000-0002-1418-6112)
- Ti Pan
Institutions
- Harbin Medical University (CN)
- National Health and Family Planning Commission (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.3389/fendo.2024.1500926
- Citations
- 3
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Harbin Medical University
- National Natural Science Foundation of China
- Chinese Center for Disease Control and Prevention